{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:56:20Z","timestamp":1785790580726,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Emergency Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ajem.2025.04.009","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:04:03Z","timestamp":1743959043000},"page":"182-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Anticoagulation for patients discharged from the emergency department with venous thromboembolism"],"prefix":"10.1016","volume":"93","author":[{"given":"Pranav","family":"Tandon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley L.","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keerat","family":"Grewal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajem.2025.04.009_bb0005","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41569-022-00787-6","article-title":"Epidemiology and prevention of venous thromboembolism","volume":"20","author":"Lutsey","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.ajem.2025.04.009_bb0010","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.ajem.2025.04.009_bb0015","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajem.2025.04.009_bb0020","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jth.12485","article-title":"Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis","volume":"12","author":"van der Hulle","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ajem.2025.04.009_bb0025","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1186\/s12913-020-5058-1","article-title":"Trends in anticoagulant prescribing: a review of local policies in English primary care","volume":"20","author":"Ho","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.ajem.2025.04.009_bb0030","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1160\/TH13-03-0243","article-title":"Patient-reported treatment satisfaction with oral rivaroxaban versus standard therapy in the treatment of acute symptomatic deep-vein thrombosis","volume":"110","author":"Bamber","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ajem.2025.04.009_bb0035","first-page":"453","article-title":"Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative study","volume":"8","author":"Seaman","year":"2014","journal-title":"Patient Prefer Adher"},{"key":"10.1016\/j.ajem.2025.04.009_bb0040","author":"Queens Printer for Ontario"},{"key":"10.1016\/j.ajem.2025.04.009_bb0045","author":"Queens Printer for Ontario"},{"issue":"48","key":"10.1016\/j.ajem.2025.04.009_bb0050","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008796","article-title":"Risk profile, management, and outcomes of patients with venous thromboembolism attended in Spanish emergency departments: the ESPHERIA registry","volume":"96","author":"Jimenez","year":"2017","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.ajem.2025.04.009_bb0055","article-title":"A clinical decision framework to guide the outpatient treatment of emergency department patients diagnosed with acute pulmonary embolism or deep vein thrombosis: results from a multidisciplinary consensus panel","volume":"2","author":"Kabrhel","year":"2021","journal-title":"J Am Coll Emerg Phys Open"},{"issue":"s1","key":"10.1016\/j.ajem.2025.04.009_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/00325481.2021.1916299","article-title":"Outpatient treatment of emergency department patients diagnosed with venous thromboembolism","volume":"133","author":"Stubblefield","year":"2021","journal-title":"Postgrad Med"},{"key":"10.1016\/j.ajem.2025.04.009_bb0065","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/PPA.S104446","article-title":"Outpatient treatment of low-risk venous thromboembolism with monotherapy oral anticoagulation: patient quality of life outcomes and clinical acceptance","volume":"10","author":"Kline","year":"2016","journal-title":"Patient Pref Adher"},{"issue":"2","key":"10.1016\/j.ajem.2025.04.009_bb0070","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02368-2020","article-title":"Survival and quality of life after early discharge in low-risk pulmonary embolism","volume":"57","author":"Barco","year":"2021","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ajem.2025.04.009_bb0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.15441\/ceem.15.096","article-title":"Admission rates for emergency department patients with venous thromboembolism and estimation of the proportion of low risk pulmonary embolism patients: a US perspective","volume":"3","author":"Singer","year":"2016","journal-title":"Clin Exp Emerg Med"},{"issue":"3","key":"10.1016\/j.ajem.2025.04.009_bb0080","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/acem.14181","article-title":"Outpatient management of patients following diagnosis of acute pulmonary embolism","volume":"28","author":"Westafer","year":"2021","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.ajem.2025.04.009_bb0085","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2025.04.009_bb0090","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ajem.2025.04.009_bb0095","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajem.2025.04.009_bb0100","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2023.7843","article-title":"Direct oral anticoagulants vs low-molecular-weight heparin and recurrent VTE in patients with cancer: a randomized clinical trial","volume":"329","author":"Schrag","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.ajem.2025.04.009_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13045-022-01289-1","article-title":"Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials","volume":"15","author":"Frere","year":"2022","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.ajem.2025.04.009_bb0110","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01647-2019","article-title":"2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society","volume":"54","author":"Konstantinides","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.ajem.2025.04.009_bb0115","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.ajem.2025.04.009_bb0120","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jaccao.2023.09.003","article-title":"Cancer-associated thrombosis: trends in clinical features, treatment, and outcomes from 2001 to 2020","volume":"5","author":"Bertoletti","year":"2023","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.ajem.2025.04.009_bb0125","first-page":"10","article-title":"Trends in anticoagulant utilization and clinical outcomes for cancer-associated thrombosis: a multicentre cohort study in Thailand\u2019s upper-middle-income country setting","author":"Kengkla","year":"2024","journal-title":"JCO Glob Oncol"}],"container-title":["The American Journal of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675725002426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735675725002426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T19:03:41Z","timestamp":1750791821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735675725002426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":25,"alternative-id":["S0735675725002426"],"URL":"https:\/\/doi.org\/10.1016\/j.ajem.2025.04.009","relation":{},"ISSN":["0735-6757"],"issn-type":[{"value":"0735-6757","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation for patients discharged from the emergency department with venous thromboembolism","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajem.2025.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}